Biotechnology
The Biotechnology industry has a total of 589 stocks, with a combined market cap of $1.36 trillion and total revenue of $115.79 billion.
Market Cap
1.36T
Revenue
115.79B
Profits
-38.76B
PE Ratio
n/a
Profit Margin
-33.47%
Dividend Yield
0.04%
589 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 138.42B | -2.12% | 803,554 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 82.65B | -1.87% | 561,087 | 15.53B |
| 3 | ARGX | argenx SE | 64.94B | -1.93% | 125,040 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 58.11B | -2.23% | 14,966,548 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 45.01B | -0.40% | 884,139 | - |
| 6 | ONC | BeOne Medicines AG | 40.73B | -1.22% | 202,355 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 36.78B | 0.13% | 3,402,547 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.61B | 0.61% | 1,430,922 | 4.80B |
| 9 | INSM | Insmed Incorporated | 27.58B | -0.31% | 1,802,543 | 1.14B |
| 10 | BNTX | BioNTech SE | 26.06B | 0.86% | 626,060 | 3.03B |
| 11 | INCY | Incyte Corporation | 25.69B | -0.98% | 1,035,962 | 5.82B |
| 12 | ROIV | Roivant Sciences Ltd. | 25.23B | 1.51% | 5,240,429 | 7.53M |
| 13 | GMAB | Genmab A/S | 20.09B | -2.35% | 1,002,596 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 17.77B | -0.21% | 719,519 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 16.02B | -0.31% | 321,834 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.63B | -0.76% | 1,540,362 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 14.62B | -0.20% | 1,580,988 | 2.44B |
| 18 | SMMT | Summit Therapeutics Inc. | 14.04B | 2.77% | 6,945,815 | - |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.88B | 0.15% | 2,298,644 | 3.41B |
| 20 | HALO | Halozyme Therapeutics, Inc. | 12.51B | -0.51% | 1,010,594 | 1.66B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.50B | -0.28% | 177,171 | 1.28B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.20B | -0.17% | 757,666 | 669.50M |
| 23 | CORT | Corcept Therapeutics Incorporated | 12.07B | -1.05% | 604,493 | 830.81M |
| 24 | TECH | Bio-Techne Corporation | 11.36B | -0.03% | 1,856,309 | 1.22B |
| 25 | AXSM | Axsome Therapeutics, Inc. | 10.83B | -0.80% | 438,239 | 776.57M |
| 26 | ABVX | ABIVAX Société Anonyme | 10.61B | 0.66% | 489,813 | 5.67M |
| 27 | KRYS | Krystal Biotech, Inc. | 10.60B | -3.56% | 319,765 | 440.48M |
| 28 | CYTK | Cytokinetics, Incorporated | 10.11B | -1.66% | 1,096,567 | 67.67M |
| 29 | PRAX | Praxis Precision Medicines, Inc. | 9.82B | -0.94% | 171,833 | 7.46M |
| 30 | KYMR | Kymera Therapeutics, Inc. | 9.76B | 0.09% | 378,565 | 105.00M |
| 31 | IONS | Ionis Pharmaceuticals, Inc. | 9.65B | -0.07% | 2,671,092 | 874.09M |
| 32 | PTGX | Protagonist Therapeutics, Inc. | 9.43B | -2.07% | 501,296 | 281.99M |
| 33 | PCVX | Vaxcyte, Inc. | 9.10B | -0.02% | 986,681 | - |
| 34 | IBRX | ImmunityBio, Inc. | 8.56B | -1.34% | 4,330,066 | 165.79M |
| 35 | IMVT | Immunovant, Inc. | 8.11B | 0.33% | 765,739 | - |
| 36 | TGTX | TG Therapeutics, Inc. | 7.94B | -1.28% | 992,941 | 799.54M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 7.85B | 1.98% | 803,823 | - |
| 38 | BLTE | Belite Bio, Inc | 7.80B | 13.16% | 735,467 | - |
| 39 | CAI | Caris Life Sciences, Inc. | 7.08B | -0.99% | 4,711,319 | 989.61M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.07B | -2.05% | 466,903 | 239.92M |
| 41 | SRRK | Scholar Rock Holding Corporation | 6.74B | -1.09% | 658,023 | - |
| 42 | CGON | CG Oncology, Inc. | 6.62B | 0.46% | 282,509 | 6.23M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.55B | 0.27% | 343,864 | 618.07M |
| 44 | TVTX | Travere Therapeutics, Inc. | 6.15B | -1.89% | 1,050,500 | 591.33M |
| 45 | ORKA | Oruka Therapeutics, Inc. | 6.13B | 1.67% | 600,469 | - |
| 46 | DNTH | Dianthus Therapeutics, Inc. | 6.05B | 0.23% | 638,464 | 1.90M |
| 47 | COGT | Cogent Biosciences, Inc. | 6.03B | -0.54% | 784,063 | - |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.79B | -1.08% | 459,130 | 7.50M |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.78B | -2.94% | 673,537 | 1.01B |
| 50 | LGND | Ligand Pharmaceuticals Incorporated | 5.69B | -1.43% | 132,386 | 290.54M |
| 51 | ERAS | Erasca, Inc. | 5.66B | -0.43% | 2,054,904 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 5.39B | -1.24% | 904,164 | 13.39M |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.12B | 0.24% | 1,128,891 | - |
| 54 | PBLS | Parabilis Medicines, Inc. | 4.99B | -0.81% | 380,617 | 148.00K |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 4.83B | 0.57% | 1,682,948 | 1.14B |
| 56 | CELC | Celcuity Inc. | 4.68B | -0.76% | 515,509 | - |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.68B | 2.67% | 828,393 | - |
| 58 | DYN | Dyne Therapeutics, Inc. | 4.53B | -2.69% | 1,588,022 | - |
| 59 | ELVN | Enliven Therapeutics, Inc. | 4.35B | -0.55% | 1,113,059 | - |
| 60 | RLAY | Relay Therapeutics, Inc. | 4.17B | 0.16% | 2,054,838 | 10.35M |
| 61 | LEGN | Legend Biotech Corporation | 4.17B | -1.06% | 812,413 | 1.27B |
| 62 | MANE | Veradermics, Incorporated | 4.12B | 0.78% | 363,117 | - |
| 63 | VKTX | Viking Therapeutics, Inc. | 4.07B | 2.62% | 1,402,465 | - |
| 64 | TLX | Telix Pharmaceuticals Limited | 4.03B | 1.70% | 142,006 | 890.79M |
| 65 | TARS | Tarsus Pharmaceuticals, Inc. | 3.98B | 9.10% | 1,595,936 | 606.33M |
| 66 | IOVA | Iovance Biotherapeutics, Inc. | 3.98B | 1.03% | 8,079,575 | 324.97M |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.85B | -0.28% | 448,007 | 234.13M |
| 68 | TNGX | Tango Therapeutics, Inc. | 3.80B | -1.05% | 1,457,354 | 53.81M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.78B | -1.56% | 736,980 | 117.00M |
| 70 | ABCL | AbCellera Biologics Inc. | 3.70B | -1.21% | 2,019,253 | 66.17M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.56B | -2.28% | 799,583 | 3.60M |
| 72 | GPCR | Structure Therapeutics Inc. | 3.38B | - | 281,703 | - |
| 73 | CLDX | Celldex Therapeutics, Inc. | 3.12B | 0.79% | 414,529 | 158.00K |
| 74 | QURE | uniQure N.V. | 3.09B | -0.80% | 991,282 | 18.67M |
| 75 | IRON | Disc Medicine, Inc. | 3.04B | -0.18% | 204,813 | - |
| 76 | IMNM | Immunome, Inc. | 3.04B | -1.47% | 562,397 | 4.02M |
| 77 | NAMS | NewAmsterdam Pharma Company N.V. | 3.04B | -1.74% | 709,503 | 7.12M |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 3.00B | 1.01% | 1,631,999 | 463.98M |
| 79 | MBX | MBX Biosciences, Inc. | 2.97B | 0.49% | 271,773 | - |
| 80 | BEAM | Beam Therapeutics Inc. | 2.96B | 0.68% | 1,182,613 | 156.04M |
| 81 | ZLAB | Zai Lab Limited | 2.94B | -2.85% | 812,771 | 449.61M |
| 82 | SLS | SELLAS Life Sciences Group, Inc. | 2.80B | 1.17% | 4,526,880 | - |
| 83 | ATAI | AtaiBeckley Inc. | 2.74B | 0.68% | 10,313,858 | 4.47M |
| 84 | NRIX | Nurix Therapeutics, Inc. | 2.71B | 3.24% | 1,232,071 | 36.77M |
| 85 | VRDN | Viridian Therapeutics, Inc. | 2.60B | -0.17% | 759,913 | 71.13M |
| 86 | VERA | Vera Therapeutics, Inc. | 2.59B | 2.57% | 1,184,640 | - |
| 87 | PGEN | Precigen, Inc. | 2.54B | -0.56% | 2,192,987 | 85.72M |
| 88 | NKTR | Nektar Therapeutics | 2.53B | -2.85% | 613,144 | 54.59M |
| 89 | MLYS | Mineralys Therapeutics, Inc. | 2.49B | -0.21% | 643,515 | - |
| 90 | PHVS | Pharvaris N.V. | 2.47B | -1.15% | 483,513 | - |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 2.46B | 0.93% | 661,470 | 959.90M |
| 92 | TRVI | Trevi Therapeutics, Inc. | 2.46B | 1.17% | 856,595 | - |
| 93 | NUVB | Nuvation Bio Inc. | 2.39B | 0.59% | 3,755,287 | 169.90M |
| 94 | SRPT | Sarepta Therapeutics, Inc. | 2.38B | -2.13% | 2,869,657 | 1.97B |
| 95 | BHVN | Biohaven Ltd. | 2.37B | -1.07% | 1,901,047 | - |
| 96 | OCUL | Ocular Therapeutix, Inc. | 2.34B | - | 1,306,834 | 52.06M |
| 97 | PVLA | Palvella Therapeutics, Inc. | 2.27B | 1.14% | 162,218 | - |
| 98 | MESO | Mesoblast Limited | 2.23B | 1.05% | 93,496 | 120.25M |
| 99 | KOD | Kodiak Sciences Inc. | 2.22B | -2.75% | 675,906 | - |
| 100 | RAPP | Rapport Therapeutics, Inc. | 2.20B | -3.95% | 279,874 | 20.00M |
| 101 | URGN | UroGen Pharma Ltd. | 2.16B | -1.76% | 779,039 | 188.73M |
| 102 | ADMA | ADMA Biologics, Inc. | 2.15B | 0.42% | 1,405,858 | 512.28M |
| 103 | ZBIO | Zenas BioPharma, Inc. | 2.14B | -0.12% | 452,688 | 1.00M |
| 104 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -0.25% | 526,575 | 311.51M |
| 105 | KLRA | Kailera Therapeutics, Inc. | 2.10B | 3.11% | 524,423 | - |
| 106 | GENB | Generate Biomedicines, Inc. | 2.10B | 0.31% | 725,332 | 26.48M |
| 107 | COAG | Hemab Therapeutics Holdings, Inc. | 2.07B | 0.59% | 301,945 | - |
| 108 | ZYME | Zymeworks Inc. | 2.07B | -2.37% | 452,925 | 37.13M |
| 109 | VCEL | Vericel Corporation | 2.06B | -0.69% | 312,911 | 306.30M |
| 110 | XNCR | Xencor, Inc. | 1.98B | -0.04% | 919,790 | 104.97M |
| 111 | AGIO | Agios Pharmaceuticals, Inc. | 1.98B | -0.09% | 480,160 | 98.34M |
| 112 | NBTX | Nanobiotix S.A. | 1.97B | -3.00% | 119,297 | 38.27M |
| 113 | KARD | Kardigan, Inc. | 1.95B | 0.53% | 279,615 | - |
| 114 | RXRX | Recursion Pharmaceuticals, Inc. | 1.95B | 5.52% | 29,039,059 | 54.86M |
| 115 | GHRS | GH Research PLC | 1.94B | 1.11% | 78,089 | - |
| 116 | VIR | Vir Biotechnology, Inc. | 1.93B | -0.57% | 1,152,028 | 303.23M |
| 117 | STOK | Stoke Therapeutics, Inc. | 1.92B | -0.60% | 714,062 | 27.59M |
| 118 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.90B | -0.68% | 1,552,055 | 208.78M |
| 119 | IMCR | Immunocore Holdings plc | 1.86B | -3.83% | 231,711 | 430.78M |
| 120 | LKFT | Lakefront Biotherapeutics NV | 1.86B | -1.83% | 208,175 | 1.13B |
| 121 | DMRA | Damora Therapeutics, Inc. | 1.86B | 7.36% | 295,825 | - |
| 122 | SNDX | Syndax Pharmaceuticals, Inc. | 1.84B | -0.58% | 1,360,746 | 252.25M |
| 123 | TSHA | Taysha Gene Therapies, Inc. | 1.82B | 0.54% | 2,111,264 | 5.49M |
| 124 | NTLA | Intellia Therapeutics, Inc. | 1.79B | 0.47% | 2,796,286 | 59.51M |
| 125 | INBX | Inhibrx Biosciences, Inc. | 1.78B | -0.89% | 194,759 | 1.30M |
| 126 | BRVE | Braveheart Bio, Inc. | 1.72B | 1.79% | 272,077 | - |
| 127 | SEPN | Septerna, Inc. | 1.72B | -0.14% | 199,663 | 98.88M |
| 128 | TYRA | Tyra Biosciences, Inc. | 1.71B | 15.25% | 1,864,288 | - |
| 129 | NVAX | Novavax, Inc. | 1.69B | -1.16% | 5,125,028 | 413.80M |
| 130 | FTRE | Fortrea Holdings Inc. | 1.68B | -4.94% | 762,077 | 2.68B |
| 131 | ANAB | AnaptysBio, Inc. | 1.68B | -1.15% | 1,061,877 | 232.39M |
| 132 | AVLN | Avalyn Pharma Inc. | 1.66B | 5.50% | 243,503 | - |
| 133 | SLBT | SL Science Holding Limited | 1.64B | -8.57% | 68,505 | 3.27M |
| 134 | AAPG | Ascentage Pharma Group International | 1.64B | 1.47% | 5,099 | 94.61M |
| 135 | LBRX | LB Pharmaceuticals Inc | 1.59B | 3.83% | 205,855 | - |
| 136 | INVA | Innoviva, Inc. | 1.54B | -0.09% | 563,384 | 440.00M |
| 137 | BCAX | Bicara Therapeutics Inc. | 1.53B | -0.73% | 296,876 | - |
| 138 | AVBP | ArriVent BioPharma, Inc. | 1.53B | -0.26% | 182,374 | - |
| 139 | APMD | Apnimed, Inc. | 1.52B | -1.29% | 233,021 | 120.15M |
| 140 | ABSI | Absci Corporation | 1.51B | 0.23% | 2,150,231 | 1.56M |
| 141 | AKTS | Aktis Oncology, Inc. | 1.50B | 1.50% | 159,246 | 10.06M |
| 142 | RARE | Ultragenyx Pharmaceutical Inc. | 1.50B | 3.03% | 11,494,472 | 717.00M |
| 143 | VOR | Vor Biopharma Inc. | 1.48B | 3.34% | 421,753 | - |
| 144 | LTGO | Latigo Biotherapeutics, Inc. | 1.46B | 2.49% | 227,437 | - |
| 145 | MAZE | Maze Therapeutics, Inc. | 1.46B | 1.31% | 273,265 | 20.00M |
| 146 | TRAX | First Tracks Biotherapeutics, Inc. | 1.45B | -4.82% | 456,212 | - |
| 147 | ALMS | Alumis Inc. | 1.44B | -2.29% | 3,077,953 | 7.40M |
| 148 | CGEM | Cullinan Therapeutics, Inc. | 1.42B | -0.32% | 562,485 | - |
| 149 | REPL | Replimune Group, Inc. | 1.42B | -1.64% | 910,228 | - |
| 150 | ANRO | Alto Neuroscience, Inc. | 1.40B | -2.34% | 269,944 | - |
| 151 | DRTS | Alpha Tau Medical Ltd. | 1.39B | 2.80% | 752,100 | - |
| 152 | ODTX | Odyssey Therapeutics, Inc. | 1.38B | 8.94% | 268,950 | 99.00K |
| 153 | OMER | Omeros Corporation | 1.37B | -0.84% | 892,179 | 38.42M |
| 154 | SVRA | Savara Inc. | 1.36B | - | 625,457 | - |
| 155 | MGTX | MeiraGTx Holdings plc | 1.33B | -0.57% | 491,060 | 397.50M |
| 156 | ORIC | ORIC Pharmaceuticals, Inc. | 1.33B | 0.94% | 991,442 | - |
| 157 | SPTX | Seaport Therapeutics, Inc. | 1.33B | 2.35% | 104,336 | - |
| 158 | IMTX | Immatics N.V. | 1.31B | 1.06% | 519,761 | 47.65M |
| 159 | MNKD | MannKind Corporation | 1.31B | 2.53% | 2,807,578 | 393.63M |
| 160 | MLTX | MoonLake Immunotherapeutics | 1.28B | -1.18% | 1,428,693 | - |
| 161 | JBIO | Jade Biosciences, Inc. | 1.27B | 0.25% | 605,018 | - |
| 162 | JANX | Janux Therapeutics, Inc. | 1.24B | 2.22% | 700,767 | 24.00M |
| 163 | CRVS | Corvus Pharmaceuticals, Inc. | 1.21B | -1.77% | 626,942 | - |
| 164 | GLUE | Monte Rosa Therapeutics, Inc. | 1.18B | -3.76% | 804,567 | 28.73M |
| 165 | KURA | Kura Oncology, Inc. | 1.18B | 0.76% | 1,313,518 | 77.23M |
| 166 | ATTO | Attovia Therapeutics, Inc. | 1.17B | 5.58% | 311,047 | 1.35M |
| 167 | SANA | Sana Biotechnology, Inc. | 1.15B | -1.79% | 1,239,802 | - |
| 168 | IVA | Inventiva S.A. | 1.11B | -1.24% | 1,350,616 | 7.94M |
| 169 | SLDB | Solid Biosciences Inc. | 1.10B | -1.63% | 495,296 | - |
| 170 | OBX | Obsidian Therapeutics, Inc. | 1.04B | -1.58% | 140,109 | - |
| 171 | FTH | Faeth Therapeutics, Inc. | 1.03B | 2.69% | 275,245 | - |
| 172 | AVTX | Avalo Therapeutics, Inc. | 1.03B | 1.21% | 633,217 | 59.00K |
| 173 | ABUS | Arbutus Biopharma Corporation | 1.02B | 0.59% | 5,198,263 | 181.72M |
| 174 | GERN | Geron Corporation | 1.01B | 3.97% | 11,478,939 | 204.56M |
| 175 | LXRX | Lexicon Pharmaceuticals, Inc. | 996.70M | -0.88% | 1,044,611 | 41.47M |
| 176 | IMMX | Immix Biopharma, Inc. | 995.11M | 0.58% | 1,050,692 | - |
| 177 | CADL | Candel Therapeutics, Inc. | 977.91M | -1.46% | 535,410 | - |
| 178 | SGP | SpyGlass Pharma, Inc. | 967.98M | -0.17% | 75,091 | - |
| 179 | ANL | Adlai Nortye Group Ltd. | 966.61M | 1.76% | 308,558 | 18.06M |
| 180 | WVE | Wave Life Sciences, Inc. | 957.65M | 3.40% | 3,030,257 | 65.37M |
| 181 | DSGN | Design Therapeutics, Inc. | 947.49M | 0.73% | 256,616 | - |
| 182 | ARDX | Ardelyx, Inc. | 941.93M | 1.89% | 2,982,307 | 450.89M |
| 183 | OLMA | Olema Pharmaceuticals, Inc. | 940.60M | 0.19% | 505,260 | - |
| 184 | ANNX | Annexon, Inc. | 923.25M | 0.62% | 1,227,540 | - |
| 185 | RIGL | Rigel Pharmaceuticals, Inc. | 909.15M | 0.35% | 104,916 | 276.79M |
| 186 | ACRS | Aclaris Therapeutics, Inc. | 908.22M | 3.70% | 1,746,642 | 8.22M |
| 187 | CBIO | Crescent Biopharma, Inc. | 893.69M | 2.35% | 239,693 | 11.88M |
| 188 | HELP | Cybin Inc. | 892.80M | 3.82% | 1,026,754 | - |
| 189 | CLYM | Climb Bio, Inc. | 891.41M | 6.37% | 1,495,263 | - |
| 190 | TBPH | Theravance Biopharma, Inc. | 886.77M | - | 160,550 | 104.31M |
| 191 | SLN | Silence Therapeutics plc | 878.45M | -1.35% | 611,151 | 615.00K |
| 192 | ACHV | Achieve Life Sciences, Inc. | 873.64M | 2.17% | 883,318 | - |
| 193 | FDMT | 4D Molecular Therapeutics, Inc. | 827.01M | 1.84% | 420,632 | 92.01M |
| 194 | CTMX | CytomX Therapeutics, Inc. | 808.41M | 0.82% | 2,297,746 | 18.30M |
| 195 | NVCT | Nuvectis Pharma, Inc. | 797.92M | 0.49% | 117,164 | - |
| 196 | PHAR | Pharming Group N.V. | 797.03M | -2.01% | 5,489 | 366.48M |
| 197 | DBVT | DBV Technologies S.A. | 793.00M | -1.68% | 43,033 | 5.04M |
| 198 | MNPR | Monopar Therapeutics Inc. | 789.08M | -0.84% | 82,202 | - |
| 199 | AURA | Aura Biosciences, Inc. | 784.01M | 2.58% | 456,392 | - |
| 200 | AGMB | AgomAb Therapeutics NV | 777.13M | 6.41% | 245,268 | - |
| 201 | NGNE | Neurogene Inc. | 772.44M | 2.63% | 205,630 | 925.00K |
| 202 | MPLT | MapLight Therapeutics, Inc. | 765.28M | 4.79% | 550,841 | - |
| 203 | PHAT | Phathom Pharmaceuticals, Inc. | 754.59M | 4.97% | 1,236,691 | 239.66M |
| 204 | OCS | Oculis Holding AG | 751.28M | - | 124,346 | 1.45M |
| 205 | ASMB | Assembly Biosciences, Inc. | 745.20M | 1.30% | 156,451 | 74.85M |
| 206 | VSTM | Verastem, Inc. | 742.62M | 2.76% | 2,301,507 | 87.53M |
| 207 | ZVRA | Zevra Therapeutics, Inc. | 736.36M | -1.12% | 1,030,003 | 136.07M |
| 208 | GYRE | Gyre Therapeutics, Inc. | 727.39M | 6.52% | 56,021 | 109.82M |
| 209 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 719.96M | 0.90% | 117,609 | - |
| 210 | STTK | Shattuck Labs, Inc. | 681.47M | -2.44% | 677,720 | 1.00M |
| 211 | ALLO | Allogene Therapeutics, Inc. | 680.62M | -0.51% | 4,428,567 | 4.64M |
| 212 | SGMT | Sagimet Biosciences Inc. | 680.02M | 0.18% | 1,250,058 | - |
| 213 | BLSM | BlossomHill Therapeutics, Inc. | 674.47M | 9.94% | 168,700 | - |
| 214 | MDXG | MiMedx Group, Inc. | 666.13M | 3.16% | 624,962 | 355.17M |
| 215 | ALT | Altimmune, Inc. | 665.25M | 5.88% | 4,871,948 | 31.00K |
| 216 | PRME | Prime Medicine, Inc. | 658.25M | -0.27% | 1,619,295 | 4.07M |
| 217 | CRMD | CorMedix Inc. | 657.07M | -0.47% | 792,685 | 462.25M |
| 218 | DRUG | Bright Minds Biosciences Inc. | 656.57M | -4.20% | 93,008 | - |
| 219 | VALN | Valneva SE | 651.26M | -2.41% | 22,865 | 163.30M |
| 220 | OABI | OmniAb, Inc. | 629.54M | -8.84% | 1,703,966 | 38.46M |
| 221 | CTNM | Contineum Therapeutics, Inc. | 628.27M | -4.95% | 346,230 | - |
| 222 | ARVN | Arvinas, Inc. | 613.98M | 0.86% | 449,294 | 316.70M |
| 223 | PROK | ProKidney Corp. | 607.67M | 4.69% | 1,225,328 | 818.00K |
| 224 | TECX | Tectonic Therapeutic, Inc. | 601.14M | 2.77% | 159,288 | - |
| 225 | ZURA | Zura Bio Limited | 597.02M | 5.95% | 1,389,462 | - |
| 226 | AUTL | Autolus Therapeutics plc | 596.20M | -2.18% | 1,836,148 | 117.39M |
| 227 | RGNX | REGENXBIO Inc. | 590.16M | -2.83% | 1,070,570 | 174.48M |
| 228 | CABA | Cabaletta Bio, Inc. | 588.32M | -0.29% | 4,891,095 | - |
| 229 | EIKN | Eikon Therapeutics, Inc. | 588.23M | -0.91% | 238,685 | - |
| 230 | PRLD | Prelude Therapeutics Incorporated | 562.35M | 4.00% | 400,284 | 22.42M |
| 231 | SPRY | ARS Pharmaceuticals, Inc. | 558.89M | -0.88% | 852,847 | 116.93M |
| 232 | EPRX | Eupraxia Pharmaceuticals Inc. | 554.49M | 12.00% | 3,521,233 | - |
| 233 | ARTV | Artiva Biotherapeutics, Inc. | 547.08M | 0.54% | 168,542 | 251.00K |
| 234 | OVID | Ovid Therapeutics Inc. | 546.83M | 0.72% | 1,065,972 | 1.58M |
| 235 | CAPR | Capricor Therapeutics, Inc. | 546.51M | 1.29% | 2,555,651 | 11.13M |
| 236 | SCTX | Scribe Therapeutics Inc. | 542.77M | -6.95% | 148,196 | 33.30M |
| 237 | ENTX | Entera Bio Ltd. | 519.43M | 1.69% | 606,922 | 42.00K |
| 238 | KYTX | Kyverna Therapeutics, Inc. | 510.21M | -1.20% | 500,780 | - |
| 239 | PRTA | Prothena Corporation plc | 504.13M | 2.29% | 383,926 | 54.53M |
| 240 | EDIT | Editas Medicine, Inc. | 496.06M | 4.87% | 1,390,650 | 47.01M |
| 241 | PBYI | Puma Biotechnology, Inc. | 492.97M | 1.49% | 185,854 | 231.24M |
| 242 | RZLT | Rezolute, Inc. | 478.46M | 0.88% | 716,867 | - |
| 243 | RLMD | Relmada Therapeutics, Inc. | 472.55M | 1.37% | 675,552 | - |
| 244 | DNA | Ginkgo Bioworks Holdings, Inc. | 468.01M | - | 656,607 | 132.42M |
| 245 | AVIR | Atea Pharmaceuticals, Inc. | 467.59M | 0.17% | 204,138 | - |
| 246 | GALT | Galectin Therapeutics Inc. | 464.92M | 5.98% | 473,478 | - |
| 247 | CCCC | C4 Therapeutics, Inc. | 462.57M | 0.53% | 2,363,306 | 35.04M |
| 248 | OCGN | Ocugen, Inc. | 461.19M | 0.74% | 3,567,525 | 4.58M |
| 249 | IKT | Inhibikase Therapeutics, Inc. | 455.19M | -0.79% | 246,955 | 1.00 |
| 250 | ARCT | Arcturus Therapeutics Holdings Inc. | 449.65M | 1.67% | 533,886 | 29.37M |
| 251 | EVMN | Evommune, Inc. | 445.30M | 2.25% | 249,090 | 10.00M |
| 252 | VOGX | Vogenx, Inc. | 441.61M | -1.31% | 89,612 | - |
| 253 | BNTC | Benitec Biopharma Inc. | 435.61M | 1.93% | 44,990 | - |
| 254 | FENC | Fennec Pharmaceuticals Inc. | 434.48M | -1.27% | 212,436 | 59.22M |
| 255 | CMPX | Compass Therapeutics, Inc. | 428.61M | 0.42% | 2,548,324 | 850.00K |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 423.73M | 1.85% | 888,538 | - |
| 257 | VTVT | vTv Therapeutics Inc. | 414.37M | -0.36% | 12,064 | 36.84M |
| 258 | ENTA | Enanta Pharmaceuticals, Inc. | 410.09M | 0.43% | 233,449 | 65.26M |
| 259 | LXEO | Lexeo Therapeutics, Inc. | 401.19M | 1.03% | 296,441 | - |
| 260 | XFOR | X4 Pharmaceuticals, Inc. | 400.55M | - | 168,162 | 15.85M |
| 261 | LRMR | Larimar Therapeutics, Inc. | 399.79M | - | 391,989 | - |
| 262 | EYPT | EyePoint, Inc. | 394.85M | 0.33% | 1,898,684 | 2.79M |
| 263 | IRD | Opus Genetics, Inc. | 388.52M | 1.52% | 2,239,579 | 9.86M |
| 264 | IPSC | Century Therapeutics, Inc. | 382.07M | 0.96% | 300,373 | 109.16M |
| 265 | ZNTL | Zentalis Pharmaceuticals, Inc. | 377.74M | -2.92% | 1,000,218 | 26.87M |
| 266 | AGEN | Agenus Inc. | 370.97M | - | 986,847 | 132.69M |
| 267 | PALI | Palisade Bio, Inc. | 364.23M | 2.20% | 1,755,318 | 500.00K |
| 268 | DMAC | DiaMedica Therapeutics Inc. | 364.00M | 2.90% | 189,481 | - |
| 269 | QTTB | Q32 Bio Inc. | 356.94M | -6.33% | 853,740 | 53.74M |
| 270 | LYEL | Lyell Immunopharma, Inc. | 352.14M | 0.35% | 54,064 | 27.00K |
| 271 | ABEO | Abeona Therapeutics Inc. | 343.10M | 1.18% | 866,504 | 25.52M |
| 272 | SABS | SAB Biotherapeutics, Inc. | 338.47M | - | 110,631 | 114.70K |
| 273 | STRO | Sutro Biopharma, Inc. | 332.78M | -2.29% | 124,764 | 45.70M |
| 274 | UPB | Upstream Bio, Inc. | 329.17M | -1.15% | 643,266 | 3.16M |
| 275 | VNDA | Vanda Pharmaceuticals Inc. | 328.31M | 1.69% | 589,313 | 215.72M |
| 276 | IFRX | InflaRx N.V. | 327.16M | -0.45% | 393,941 | -11.54K |
| 277 | SION | Sionna Therapeutics, Inc. | 324.63M | 6.37% | 926,065 | - |
| 278 | PYXS | Pyxis Oncology, Inc. | 324.46M | 9.12% | 2,230,891 | 11.04M |
| 279 | VCRE | Vicore Pharma Holding AB (publ) | 320.75M | 0.35% | 14,661 | 412.09K |
| 280 | IMRX | Immuneering Corporation | 311.84M | -4.37% | 1,000,331 | - |
| 281 | OBIO | Orchestra BioMed Holdings, Inc. | 305.33M | 7.17% | 478,138 | 31.98M |
| 282 | BCYC | Bicycle Therapeutics plc | 300.97M | 1.42% | 157,457 | 61.21M |
| 283 | FATE | Fate Therapeutics, Inc. | 297.15M | 2.48% | 611,431 | 6.49M |
| 284 | CUVL | Clinuvel Pharmaceuticals Limited | 296.25M | 3.82% | 79,283 | 65.05M |
| 285 | FULC | Fulcrum Therapeutics, Inc. | 293.74M | 0.26% | 1,004,638 | 80.00M |
| 286 | FHTX | Foghorn Therapeutics Inc. | 292.18M | 1.03% | 266,014 | 36.74M |
| 287 | PRQR | ProQR Therapeutics N.V. | 292.12M | -0.96% | 368,448 | 21.05M |
| 288 | TTRX | Turn Therapeutics Inc. | 291.92M | -2.68% | 70,574 | - |
| 289 | ACIU | AC Immune SA | 284.36M | -2.39% | 155,623 | 21.67M |
| 290 | RNAC | Cartesian Therapeutics, Inc. | 280.47M | 1.64% | 68,350 | 1.48M |
| 291 | MGNX | MacroGenics, Inc. | 280.28M | 3.53% | 442,675 | 175.14M |
| 292 | ALXO | ALX Oncology Holdings Inc. | 277.94M | -0.99% | 301,113 | - |
| 293 | CAMP | Camp4 Therapeutics Corporation | 276.74M | -1.78% | 131,024 | 4.22M |
| 294 | ALEC | Alector, Inc. | 274.68M | -1.99% | 496,598 | 13.86M |
| 295 | LCTX | Lineage Cell Therapeutics, Inc. | 273.14M | -1.82% | 535,694 | 13.08M |
| 296 | SRZN | Surrozen, Inc. | 267.51M | 0.98% | 150,235 | 11.51M |
| 297 | AVXL | Anavex Life Sciences Corp. | 265.11M | 0.35% | 307,048 | - |
| 298 | WHWK | Whitehawk Therapeutics, Inc. | 262.24M | -0.65% | 178,140 | 7.15M |
| 299 | TRDA | Entrada Therapeutics, Inc. | 257.09M | -0.56% | 341,729 | 4.69M |
| 300 | NAGE | Niagen Bioscience, Inc. | 251.36M | 1.93% | 256,765 | 129.08M |
| 301 | NGEN | NervGen Pharma Corp. | 250.53M | 0.43% | 920,469 | - |
| 302 | YDES | YD Bio Limited | 248.93M | -3.54% | 687,083 | 510.36K |
| 303 | VRXA | Veraxa Biotech AG | 248.88M | 15.03% | 3,582,282 | 29.54K |
| 304 | NMRA | Neumora Therapeutics, Inc. | 246.14M | -2.96% | 549,208 | - |
| 305 | ELDN | Eledon Pharmaceuticals, Inc. | 245.65M | 3.07% | 1,197,765 | - |
| 306 | CGEN | Compugen Ltd. | 245.34M | 1.37% | 199,695 | 74.00M |
| 307 | IVVD | Invivyd, Inc. | 243.47M | -1.08% | 1,960,761 | 58.37M |
| 308 | RNA | Atrium Therapeutics, Inc. | 242.73M | -2.81% | 167,784 | 35.84M |
| 309 | ADAG | Adagene Inc. | 240.37M | -2.98% | 28,142 | 9.29M |
| 310 | CLLS | Cellectis S.A. | 236.89M | -2.41% | 4,833 | 63.82M |
| 311 | GLSI | Greenwich LifeSciences, Inc. | 234.12M | 2.05% | 64,838 | - |
| 312 | TARA | Protara Therapeutics, Inc. | 232.84M | -0.76% | 203,006 | - |
| 313 | ABOS | Acumen Pharmaceuticals, Inc. | 229.97M | 2.91% | 315,368 | - |
| 314 | SLGL | Sol-Gel Technologies Ltd. | 227.61M | -0.83% | 29,626 | 1.80M |
| 315 | TNXP | Tonix Pharmaceuticals Holding Corp. | 225.36M | -1.72% | 252,491 | 29.10M |
| 316 | KROS | Keros Therapeutics, Inc. | 224.44M | 1.89% | 65,634 | 15.01M |
| 317 | ANTX | AN2 Therapeutics, Inc. | 222.27M | -1.01% | 77,182 | - |
| 318 | CHRS | Coherus Oncology, Inc. | 219.39M | 3.65% | 306,060 | 50.94M |
| 319 | ARMP | Armata Pharmaceuticals, Inc. | 217.14M | 5.80% | 48,032 | 5.54M |
| 320 | VYGR | Voyager Therapeutics, Inc. | 216.28M | 3.85% | 406,740 | 34.46M |
| 321 | PEPG | PepGen Inc. | 215.40M | -2.20% | 200,999 | - |
| 322 | PLX | Protalix BioTherapeutics, Inc. | 215.13M | 1.91% | 863,718 | 80.62M |
| 323 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 214.30M | -3.32% | 222,588 | - |
| 324 | NERV | Minerva Neurosciences, Inc. | 211.52M | -5.54% | 78,424 | - |
| 325 | NKTX | Nkarta, Inc. | 209.14M | 4.66% | 447,412 | - |
| 326 | NBP | NovaBridge Biosciences | 208.80M | - | 71,520 | - |
| 327 | ORMP | Oramed Pharmaceuticals Inc. | 208.40M | 1.62% | 226,851 | 2.00M |
| 328 | ACOG | Alpha Cognition Inc. | 207.33M | 3.37% | 45,936 | 15.26M |
| 329 | DTIL | Precision BioSciences, Inc. | 206.18M | 1.36% | 124,284 | 45.06M |
| 330 | CUE | Cue Biopharma, Inc. | 199.34M | -0.83% | 50,415 | 37.66M |
| 331 | IPHA | Innate Pharma S.A. | 191.23M | -1.42% | 8,979 | 10.57M |
| 332 | MSLE | Satellos Bioscience Inc. | 190.92M | -1.21% | 25,690 | - |
| 333 | LENZ | LENZ Therapeutics, Inc. | 187.27M | 2.23% | 488,916 | 21.48M |
| 334 | CNTN | Canton Strategic Holdings, Inc. | 181.67M | 1.33% | 410,642 | 1.50M |
| 335 | KRRO | Korro Bio, Inc. | 180.24M | 5.34% | 78,428 | 2.38M |
| 336 | IMUX | Immunic, Inc. | 178.88M | 2.74% | 421,291 | - |
| 337 | MENS | Jyong Biotech Ltd. | 177.42M | 5.29% | 50,995 | - |
| 338 | MDWD | MediWound Ltd. | 171.58M | 0.61% | 86,155 | 11.86M |
| 339 | MIST | Milestone Pharmaceuticals Inc. | 169.09M | -0.83% | 1,592,762 | 2.34M |
| 340 | KZIA | Kazia Therapeutics Limited | 168.69M | 1.23% | 414,432 | 1.27M |
| 341 | CRBU | Caribou Biosciences, Inc. | 168.32M | - | 1,329,447 | 10.04M |
| 342 | HUMA | Humacyte, Inc. | 168.04M | 1.49% | 2,965,239 | 2.12M |
| 343 | SPRB | Spruce Biosciences, Inc. | 166.49M | 0.38% | 104,946 | 697.00K |
| 344 | MOLN | Molecular Partners AG | 165.12M | - | 2,167 | 856.30K |
| 345 | INDP | Indaptus Therapeutics, Inc. | 162.56M | 5.17% | 133,111 | - |
| 346 | OTLK | Outlook Therapeutics, Inc. | 162.26M | 2.70% | 6,395,728 | -1.16M |
| 347 | CDXS | Codexis, Inc. | 159.88M | 2.82% | 757,823 | 77.68M |
| 348 | TNYA | Tenaya Therapeutics, Inc. | 153.19M | -1.74% | 1,206,134 | 1.34M |
| 349 | NRXP | NRx Pharmaceuticals, Inc. | 150.99M | 1.75% | 487,528 | 3.39M |
| 350 | INO | Inovio Pharmaceuticals, Inc. | 147.86M | 5.15% | 2,910,140 | 65.34K |
| 351 | BMEA | Biomea Fusion, Inc. | 147.14M | 6.28% | 3,291,010 | - |
| 352 | OKUR | OnKure Therapeutics, Inc. | 144.98M | 0.56% | 165,390 | - |
| 353 | UNCY | Unicycive Therapeutics, Inc. | 143.73M | -2.64% | 492,854 | - |
| 354 | EQ | Equillium, Inc. | 140.13M | -0.45% | 225,905 | 4.39M |
| 355 | HURA | TuHURA Biosciences, Inc. | 136.37M | 1.90% | 367,762 | - |
| 356 | VANI | Vivani Medical, Inc. | 134.40M | 7.19% | 481,504 | - |
| 357 | CNXU | Conexeu Sciences Inc. | 132.99M | -5.69% | 249,382 | - |
| 358 | TLSA | Tiziana Life Sciences Ltd | 131.89M | 4.67% | 573,920 | - |
| 359 | NTHI | NeOnc Technologies Holdings, Inc. | 125.03M | 5.01% | 102,274 | 39.99K |
| 360 | ENGN | enGene Therapeutics Inc. | 121.92M | -0.55% | 412,676 | - |
| 361 | BDTX | Black Diamond Therapeutics, Inc. | 121.80M | 0.95% | 324,716 | 70.00M |
| 362 | CBUS | Cibus, Inc. | 121.52M | 0.63% | 73,947 | 4.35M |
| 363 | RANI | Rani Therapeutics Holdings, Inc. | 120.62M | 1.54% | 381,093 | 4.88M |
| 364 | AARD | Aardvark Therapeutics, Inc. | 117.74M | -6.11% | 257,809 | - |
| 365 | CNTB | Connect Biopharma Holdings Limited | 115.87M | -4.66% | 2,412,220 | 2.95M |
| 366 | NAUT | Nautilus Biotechnology, Inc. | 115.15M | -1.59% | 579,435 | 190.00K |
| 367 | PMN | ProMIS Neurosciences, Inc. | 112.99M | -2.33% | 23,983 | - |
| 368 | COYA | Coya Therapeutics, Inc. | 111.66M | 4.62% | 75,758 | 8.02M |
| 369 | TENX | Tenax Therapeutics, Inc. | 111.13M | 8.99% | 4,542,529 | - |
| 370 | GUTS | Fractyl Health, Inc. | 110.88M | 1.35% | 440,198 | 3.00K |
| 371 | PYPD | PolyPid Ltd. | 109.48M | 2.28% | 73,095 | - |
| 372 | GNLX | Genelux Corporation | 109.34M | -3.17% | 296,534 | 8.00K |
| 373 | SEER | Seer, Inc. | 107.98M | 0.52% | 68,795 | 14.22M |
| 374 | RNXT | RenovoRx, Inc. | 107.86M | 0.84% | 2,092,362 | 1.98M |
| 375 | ONCY | Oncolytics Biotech Inc. | 107.52M | -1.55% | 463,705 | - |
| 376 | ANIX | Anixa Biosciences, Inc. | 104.45M | 0.66% | 368,209 | - |
| 377 | ACET | Adicet Bio, Inc. | 103.23M | 1.70% | 44,608 | - |
| 378 | PLYX | Polaryx Therapeutics, Inc. | 99.69M | 0.50% | 39,725 | - |
| 379 | ATRA | Atara Biotherapeutics, Inc. | 97.97M | 2.41% | 135,655 | 6.19M |
| 380 | CGTX | Cognition Therapeutics, Inc. | 97.95M | -1.90% | 377,455 | - |
| 381 | PMVP | PMV Pharmaceuticals, Inc. | 97.41M | 4.03% | 529,981 | - |
| 382 | PTHS | Pelthos Therapeutics Inc. | 93.22M | -0.04% | 18,796 | 43.30M |
| 383 | KLRS | Kalaris Therapeutics, Inc. | 92.84M | -1.02% | 23,861 | - |
| 384 | ACRV | Acrivon Therapeutics, Inc. | 91.28M | 3.40% | 184,474 | - |
| 385 | VRCA | Verrica Pharmaceuticals Inc. | 91.05M | -1.12% | 12,197 | 30.32M |
| 386 | FBIO | Fortress Biotech, Inc. | 90.71M | 0.37% | 168,115 | 68.47M |
| 387 | ICCC | ImmuCell Corporation | 89.91M | -1.00% | 11,692 | 30.68M |
| 388 | RLYB | Rallybio Corporation | 89.88M | 0.27% | 4,180 | 646.00K |
| 389 | ALDX | Aldeyra Therapeutics, Inc. | 89.28M | - | 486,182 | - |
| 390 | OSTX | OS Therapies Incorporated | 86.72M | 3.30% | 982,579 | - |
| 391 | GOSS | Gossamer Bio, Inc. | 85.69M | -0.17% | 8,093,290 | 53.29M |
| 392 | CRDF | Cardiff Oncology, Inc. | 84.80M | 0.93% | 437,279 | 508.00K |
| 393 | YARW | Yarrow Bioscience, Inc. | 84.59M | 4.71% | 26,472 | - |
| 394 | IBIO | iBio, Inc. | 84.24M | 0.77% | 265,432 | 100.00K |
| 395 | OKYO | OKYO Pharma Limited | 82.39M | 1.29% | 32,935 | - |
| 396 | MAIA | MAIA Biotechnology, Inc. | 80.29M | -0.75% | 243,248 | - |
| 397 | MNOV | MediciNova, Inc. | 80.23M | 0.62% | 96,718 | 920.48K |
| 398 | TELO | Telomir Pharmaceuticals, Inc. | 79.78M | - | 33,918 | - |
| 399 | ATHE | Alterity Therapeutics Limited | 78.75M | 0.44% | 4,494 | 2.50M |
| 400 | GANX | Gain Therapeutics, Inc. | 78.56M | -1.10% | 205,348 | - |
| 401 | DWTX | Dogwood Therapeutics, Inc. | 77.84M | -2.97% | 70,158 | - |
| 402 | RNTX | Rein Therapeutics Inc. | 76.70M | 5.39% | 986,034 | - |
| 403 | NRXS | NeurAxis, Inc. | 74.84M | -1.81% | 47,234 | 5.32M |
| 404 | CING | Cingulate Inc. | 74.16M | -2.30% | 106,974 | - |
| 405 | NTRB | Nutriband Inc. | 72.57M | 6.04% | 96,191 | 1.62M |
| 406 | CSBR | Champions Oncology, Inc. | 72.52M | -1.14% | 10,916 | 59.43M |
| 407 | PLRX | Pliant Therapeutics, Inc. | 71.83M | 2.65% | 559,894 | - |
| 408 | LONA | LeonaBio, Inc. | 71.23M | -1.82% | 14,067 | - |
| 409 | SPRO | Spero Therapeutics, Inc. | 70.46M | -0.82% | 362,983 | 47.00M |
| 410 | SER | Serina Therapeutics, Inc. | 69.34M | 1.49% | 14,953 | 130.00K |
| 411 | INMB | INmune Bio Inc. | 67.72M | 7.49% | 323,961 | 50.00K |
| 412 | XBIT | XBiotech Inc. | 67.07M | - | 118,606 | - |
| 413 | BSEM | BioStem Technologies, Inc. | 66.22M | 2.77% | 87,405 | 34.59M |
| 414 | HRTX | Heron Therapeutics, Inc. | 65.29M | 4.21% | 1,878,452 | 151.18M |
| 415 | BOLD | Boundless Bio, Inc. | 65.28M | 0.35% | 20,000 | - |
| 416 | EDSA | Edesa Biotech, Inc. | 63.91M | -0.63% | 36,322 | - |
| 417 | EXOZ | eXoZymes, Inc. | 63.58M | 0.74% | 1,306 | -700.00 |
| 418 | ELTX | Elicio Therapeutics, Inc. | 63.34M | -3.60% | 487,870 | - |
| 419 | ALPS | Alps Group Inc | 63.23M | - | 48,642 | 3.74M |
| 420 | HYFT | MindWalk Holdings Corp. | 62.02M | -0.75% | 91,935 | 11.43M |
| 421 | ELOX | Eloxx Pharmaceuticals, Inc. | 60.55M | 5.71% | 38,842 | - |
| 422 | APLM | Apollomics, Inc. | 60.38M | -1.84% | 1,518 | 8.84M |
| 423 | INKT | MiNK Therapeutics, Inc. | 59.40M | 3.65% | 5,846 | - |
| 424 | ANVS | Annovis Bio, Inc. | 59.22M | 0.72% | 1,532,940 | - |
| 425 | XLO | Xilio Therapeutics, Inc. | 59.22M | -0.22% | 7,637 | 64.09M |
| 426 | IBO | Impact BioMedical Inc. | 58.22M | 12.50% | 4,133,710 | 35.00K |
| 427 | MCRB | Seres Therapeutics, Inc. | 56.86M | 1.42% | 36,445 | 1.88M |
| 428 | IMA | ImageneBio, Inc. | 55.05M | -0.72% | 15,462 | 800.00K |
| 429 | TIL | Instil Bio, Inc. | 51.41M | -1.04% | 2,949 | - |
| 430 | HYPD | Hyperion DeFi, Inc. | 51.28M | - | 321,954 | 1.40M |
| 431 | IMMP | Immutep Limited | 50.99M | -0.05% | 62,555 | 13.79M |
| 432 | ATYR | aTyr Pharma, Inc. | 48.78M | -1.23% | 253,792 | 190.00K |
| 433 | CELU | Celularity Inc. | 48.63M | -8.20% | 351,085 | 26.55M |
| 434 | TVGN | Tevogen Inc. | 47.79M | 2.37% | 1,943 | - |
| 435 | HOWL | Werewolf Therapeutics, Inc. | 46.96M | 2.38% | 489,800 | 21.00M |
| 436 | VERU | Veru Inc. | 45.01M | -0.38% | 143,541 | 16.89M |
| 437 | MGX | Metagenomi Therapeutics, Inc. | 44.20M | 0.86% | 54,793 | 13.56M |
| 438 | GRCE | Grace Therapeutics, Inc. | 44.18M | -1.87% | 186,771 | - |
| 439 | KPTI | Karyopharm Therapeutics Inc. | 40.60M | 1.13% | 577,722 | 146.62M |
| 440 | MREO | Mereo BioPharma Group plc | 39.92M | -8.16% | 1,338,932 | 500.00K |
| 441 | FLNA | Filana Therapeutics, Inc. | 39.62M | -0.99% | 285,998 | - |
| 442 | LITS | Lite Strategy, Inc. | 38.79M | 9.62% | 159,917 | - |
| 443 | ALGS | Aligos Therapeutics, Inc. | 38.78M | -0.16% | 20,253 | 31.52M |
| 444 | CRVO | CervoMed Inc. | 38.70M | 0.79% | 108,524 | 331.30K |
| 445 | NXTC | NextCure, Inc. | 35.79M | -0.26% | 60,631 | - |
| 446 | ACTU | Actuate Therapeutics, Inc. | 35.54M | 8.03% | 1,322,855 | - |
| 447 | RNAZ | TransCode Therapeutics, Inc. | 34.88M | -4.41% | 10,408 | - |
| 448 | KYNB | Kyntra Bio, Inc. | 34.62M | 0.71% | 11,904 | 4.62M |
| 449 | CNTX | Context Therapeutics Inc. | 33.23M | -0.36% | 975,428 | - |
| 450 | ATNM | Actinium Pharmaceuticals, Inc. | 32.38M | -1.90% | 54,229 | 35.09M |
| 451 | QNCX | Quince Therapeutics, Inc. | 31.85M | 2.52% | 37,859 | - |
| 452 | BRNS | Barinthus Biotherapeutics plc | 31.00M | 5.50% | 226,787 | 14.97M |
| 453 | BCTX | BriaCell Therapeutics Corp. | 31.00M | 1.13% | 108,238 | - |
| 454 | IGC | IGC Pharma, Inc. | 30.81M | -0.17% | 378,027 | 1.11M |
| 455 | CVM | CEL-SCI Corporation | 28.67M | 1.24% | 75,071 | - |
| 456 | RADX | Radiopharm Theranostics Limited | 28.14M | -3.48% | 7,909 | 9.34M |
| 457 | ESLA | Estrella Immunopharma, Inc. | 28.11M | 0.83% | 69,522 | - |
| 458 | TCRX | TScan Therapeutics, Inc. | 26.54M | 5.55% | 1,674,503 | 7.11M |
| 459 | QNTM | Quantum BioPharma Ltd. | 26.36M | 9.83% | 110,925 | - |
| 460 | EVAX | Evaxion A/S | 26.02M | 1.30% | 38,327 | 7.49M |
| 461 | NNVC | NanoViricides, Inc. | 25.51M | -2.61% | 489,457 | - |
| 462 | TVRD | Tvardi Therapeutics, Inc. | 25.48M | 3.24% | 73,217 | - |
| 463 | BYSI | BeyondSpring Inc. | 25.42M | -0.66% | 26,911 | 1.88M |
| 464 | ATOS | Atossa Therapeutics, Inc. | 25.15M | -0.40% | 27,979 | - |
| 465 | ABVC | ABVC BioPharma, Inc. | 24.89M | -3.99% | 142,448 | 797.92K |
| 466 | LTRN | Lantern Pharma Inc. | 24.35M | 1.87% | 134,521 | - |
| 467 | JSPR | Jasper Therapeutics, Inc. | 23.58M | 3.23% | 432,928 | - |
| 468 | LEXX | Lexaria Bioscience Corp. | 23.38M | 14.85% | 22,428 | 194.00K |
| 469 | GRDX | GridAI Technologies Corp. | 23.01M | 9.43% | 84,500 | - |
| 470 | PTN | Palatin Technologies, Inc. | 22.68M | -2.91% | 257,715 | 12.88M |
| 471 | GNTA | Genenta Science S.p.A. | 22.65M | 1.01% | 31,642 | - |
| 472 | ALLR | Allarity Therapeutics, Inc. | 22.59M | -0.70% | 56,669 | 345.00K |
| 473 | CLRB | Cellectar Biosciences, Inc. | 22.40M | 0.85% | 26,570 | - |
| 474 | AKTX | Akari Therapeutics, Plc | 22.33M | 5.81% | 108,637 | - |
| 475 | COCP | Cocrystal Pharma, Inc. | 21.77M | - | 43,422 | 330.00K |
| 476 | LGVN | Longeveron Inc. | 21.71M | 3.50% | 41,236 | 1.19M |
| 477 | PLRZ | Polyrizon Ltd. | 21.04M | -10.51% | 141,260 | - |
| 478 | CNSY | Cerenome, Inc. | 20.91M | -7.55% | 35,288 | 4.20M |
| 479 | NEUP | Neuphoria Therapeutics Inc. | 20.38M | 0.27% | 21,886 | -13.27K |
| 480 | LPCN | Lipocine Inc. | 20.20M | 1.24% | 23,102 | 1.57M |
| 481 | MRKR | Marker Therapeutics, Inc. | 19.67M | -4.84% | 35,506 | 3.55M |
| 482 | CMMB | Chemomab Therapeutics Ltd. | 19.64M | -4.24% | 118,507 | - |
| 483 | CYCN | Cyclerion Therapeutics, Inc. | 19.58M | -14.31% | 104,011 | 1.90M |
| 484 | KTTA | Pasithea Therapeutics Corp. | 19.38M | -0.07% | 222,701 | - |
| 485 | NCEL | NewcelX Ltd. | 19.35M | - | 1,410 | - |
| 486 | ENLV | Enlivex Ltd. | 19.23M | -5.17% | 252,091 | - |
| 487 | DYAI | Dyadic International, Inc. | 18.96M | 3.89% | 126,939 | 3.80M |
| 488 | NRSN | NeuroSense Therapeutics Ltd. | 18.89M | 27.19% | 4,224,384 | - |
| 489 | ADIL | Adial Pharmaceuticals, Inc. | 18.70M | 6.91% | 50,058 | - |
| 490 | NIKI | Niki BioSolutions, Inc. | 18.22M | -4.76% | 4,135,141 | - |
| 491 | PBM | Psyence Biomedical Ltd. | 17.32M | 2.48% | 27,741 | - |
| 492 | TPST | Tempest Therapeutics, Inc. | 16.46M | -1.90% | 214,633 | - |
| 493 | BCDA | BioCardia, Inc. | 16.35M | -0.92% | 58,197 | 3.00K |
| 494 | CTXR | Citius Pharmaceuticals, Inc. | 16.13M | -2.38% | 299,502 | 7.11M |
| 495 | HIND | Vyome Holdings, Inc. | 15.58M | -0.45% | 2,266 | 129.73K |
| 496 | BIVI | BioVie Inc. | 15.09M | -1.48% | 296,762 | - |
| 497 | PASG | Passage Bio, Inc. | 14.96M | -2.11% | 3,754 | - |
| 498 | LSTA | Lisata Therapeutics, Inc. | 14.87M | 0.61% | 33,892 | 100.00K |
| 499 | CALC | CalciMedica, Inc. | 14.82M | -1.36% | 94,117 | - |
| 500 | PLUR | Pluri Inc. | 14.67M | -0.73% | 15,450 | 1.08M |